The cardiac natriuretic peptides (NP)-atrial natriuretic factor (ANF)
and brain natriuretic peptide (BNP)-are polypeptide hormones produced
by cardiocytes in the atria of mammals. ANF and BNP are continuously r
eleased from the heart, but appropriate mechanical or neuroendocrine s
timuli increase their rate of release with or without a concomitant in
crease in synthesis, The results of our investigations lead us to prop
ose that the endocrine response of the heart to pressure or volume loa
d varies in relation to whether the challenge is acute, subacute or ch
ronic. The acute response to stretch is based on a phenomenon referred
to as ''stretch-secretion coupling'' which results in enhanced secret
ion of NP stored in the atria. NP release following stretch is made at
the expense of a depletable NP pool with no apparent effect on synthe
sis. The stimulation of NP production that is seen during mineralocort
icoid escape is referred to as ''subacute'' and is characterized by st
imulation of atrial ANF and BNP gene transcription secondary to volume
overload in which plasma ANF, but not plasma BNP, is significantly el
evated. With chronic stimulation, as seen in DOCA-salt treatment at th
e hypertensive stage, activation of the cardiac fetal program in ventr
icle is seen together with a stimulation of ANF and BNP production in
both atria and ventricles. However, the activation of NP gene expressi
on in the atria is not necessarily associated with fetal isogene expre
ssion even though the ventricular hypertrophic process is characterize
d by the expression of fetal isogenes, including ANF and BNP, that are
normally expressed in the fetal ventricle. It seems likely that the a
cute stimulation of NP release is based on an electromechanical coupli
ng. However, protracted stimulation of release is seen in situations i
n which profound neuroendocrine changes have taken place, thus suggest
ing that the primary stimulus for chronically enhanced NP gene express
ion and NP release is based on changes in the hormonal environment of
the atrial cardiocyte. It is concluded that the endocrine heart respon
ds to changes in hemodynamic load with specific changes in translation
al, post-translational and storage processes for ANF and BNP following
acute or chronic stimulation. As a result, plasma levels of ANF and B
NP may be used as indicators of the degree of atrial hemodynamic overl
oad and ventricular hypertrophy, respectively. It may be advanced that
the endocrine heart differentiates and responds to different hemodyna
mic challenges in either acute or chronic conditions with specific cha
nges in transcription, translation, post-translational processing, sto
rage, and release of ANF and BNP, We propose that this differentiation
is part of the reason for the heart to produce two hormones with simi
lar spectra of activity. This paradigm warrants further investigation.